Castle Biosciences
NASDAQ: CSTL3 known investors
Castle Biosciences develops genomic tests that provide personalized biological information to inform disease diagnosis, treatment selection, and follow-up care decisions for healthcare providers and patients. The company operates in precision genomics and clinical diagnostics focused on improving patient outcomes.